Prescribing COVID-19 treatments: what we should never forget
- PMID: 32405110
- PMCID: PMC7219411
- DOI: 10.1016/j.jinf.2020.05.018
Prescribing COVID-19 treatments: what we should never forget
Comment in
-
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.J Infect. 2020 Aug;81(2):e117-e119. doi: 10.1016/j.jinf.2020.05.058. Epub 2020 May 28. J Infect. 2020. PMID: 32474031 Free PMC article. No abstract available.
Similar articles
-
Statins in coronavirus outbreak: It's time for experimental and clinical studies.Pharmacol Res. 2020 Jun;156:104803. doi: 10.1016/j.phrs.2020.104803. Epub 2020 Apr 11. Pharmacol Res. 2020. PMID: 32289478 Free PMC article. No abstract available.
-
Is the type of diabetes treatment relevant to outcome of COVID-19?J Diabetes. 2020 Jul;12(7):486-487. doi: 10.1111/1753-0407.13047. J Diabetes. 2020. PMID: 32353193 Free PMC article. No abstract available.
-
[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].Virologie (Montrouge). 2020 Jun 1;24(3):135-141. doi: 10.1684/vir.2020.0843. Virologie (Montrouge). 2020. PMID: 32648548 French. No abstract available.
-
Psychopharmacology of COVID-19.Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18. Psychosomatics. 2020. PMID: 32425246 Free PMC article. Review.
-
Pros and cons of corticosteroid therapy for COVID-19 patients.Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10. Respir Physiol Neurobiol. 2020. PMID: 32659271 Free PMC article. Review.
Cited by
-
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.J Infect. 2020 Aug;81(2):e117-e119. doi: 10.1016/j.jinf.2020.05.058. Epub 2020 May 28. J Infect. 2020. PMID: 32474031 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources